Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2NETWORK 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Dermatologic 1

Conditions

Sezary Syndrome 2Mycosis Fungoides 2Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Lymphoma, T-Cell, Cutaneous 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia 1Anemia, Refractory, with Excess of Blasts 1Anemia, Refractory 1

Interventions

Radiotherapy 2Methoxsalen 2merphos 1liposomal amphotericin B 1imetelstat 1atezolizumab 1Whole-Body Irradiation 1Watchful Waiting 1Vorinostat 1Vincristine 1VAP-cyclo protocol 1Ultraviolet Therapy 1Prednisone 1Photopheresis 1Pentostatin 1Palliative Care 1Nutritional Support 1Nicotine 1Mycophenolic Acid 1Moxifloxacin 1Morphine 1Methotrexate 1Lenalidomide 1Etoposide 1EPOCH protocol 1Doxorubicin 1Dextromethorphan 1Cyclosporins 1Cyclosporine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Sezary Syndrome × Methoxsalen × Clear all
NCT03563040 2021-09-08

PROMPT

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Withdrawn
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT00056056 2018-07-09

Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Terminated
93 enrolled
Lymphoid

Lymphoma, Mycosis Fungoides, Sezary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡